Operation Warp Speed redux: HHS awards $1.4B to develop next-gen Covid-19 drugs and vaccines

HHS on Tuesday announced it’s pumping $1.4 billion in government funds into next-gen Covid-19 medical products in the pipeline, including $326 million to Regeneron to help develop a Covid-19 monoclonal antibody.

The announcement is the first public step forward for Project NextGen, which aims to spend $5 billion on developing new Covid-19 therapies and vaccines, the Biden administration announced in May.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Exclusive: Marc Tessier-Lavigne on leaving Stanford and joining biotech’s new AI mega-startup

Earlier Tuesday, Endpoints News reported that former Stanford president Marc Tessier-Lavigne will lead one of biotech’s biggest-ever startup launches: Xaira Therapeutics, which has secured over

April 24, 2024

Maternal metabolic conditions linked to children’s neurodevelopmental risks, study shows

Study investigates how maternal metabolic conditions like pregestational diabetes, gestational diabetes, and obesity mediate the risk of neurodevelopmental conditions in children. It highlights the significant

November 13, 2023

Inflammatory Bowel Disease Linked With Increased Stroke Risk

Patients with inflammatory bowel disease (IBD) were 13% more likely to suffer a stroke than the general population, even decades after their diagnosis, according to

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.